← Eichor
Study identifier: NCT06975111 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

Condition: Menopause · Menopause Hot Flashes · Menopause Related Conditions  ·  Sponsor: University of Colorado, Denver

PhasePhase 2/Phase 3
Planned participants200
Who can joinFemale, 45 Years to 55 Years
Healthy volunteersYes

About this study

What if midlife women, who are inherently at an increased risk for future cardiometabolic disease due to transitioning into menopause, had access to a suite of evidence-based health interventions? Could these interventions reduce menopause-related inflammation, restore a healthier cardiometabolic profile, reverse epigenetic aging, and reduce bothersome menopausal symptoms? The ultimate goal of this work is to attenuate future disease and enhance women's quality of life, extend healthspan and increase productivity.

This description comes directly from the study's public registry record.

Talk to the study team

Carrie Hsu, BA  ·  303-724-5276  ·  carrie.hsu@cuanschutz.edu

Nalia Naushad  ·  naila.naushad@cuanschutz.edu

Always discuss trial participation with your own doctor first.

Locations (3)

University of Colorado-School of MedicineAurora, Colorado, United StatesRecruiting
University of North Carolina, School of MedicineChapel Hill, North Carolina, United StatesRecruiting
Virginia Commonwealth UniversityRichmond, Virginia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06975111